A 'normal' TSH is not always reassuring. When FT4 is low, a normal TSH suggests the pituitary is not responding appropriately — and that is a different problem from primary thyroid disease.
CLINICAL PRINTABLE
Coming Soon.
A one-page TSH + Free T4 clinical reference is on the way.
1 · What the Result Actually Means
TSH reflects pituitary signaling to the thyroid; free T4 reflects circulating unbound thyroxine. In most adults with an intact pituitary, TSH is an excellent first test, but pairing abnormal TSH with FT4 distinguishes overt from subclinical disease and helps identify patterns that do not fit primary thyroid disease.
The common error is assuming TSH alone always tells you whether the thyroid is underactive or overactive. It does not — particularly when pituitary or hypothalamic disease is present, when the patient is acutely ill, or when medications or supplements are interfering with the assay.
2 · Practical Interpretation Framework
High TSH + low FT4: primary overt hypothyroidism pattern.
High TSH + normal FT4: subclinical hypothyroidism pattern. Treatment decisions depend on degree and persistence, symptoms, antibodies, pregnancy context, age, and cardiovascular factors.
Low TSH + high FT4 (and/or T3): hyperthyroid or thyrotoxic pattern. Determine the cause — Graves' disease, toxic nodule, thyroiditis, exogenous thyroid hormone.
Low TSH + normal FT4/T3: subclinical hyperthyroidism pattern. Persistence and patient risk — atrial fibrillation risk, bone density, age — matter.
Low or inappropriately normal TSH + low FT4: think central hypothyroidism from pituitary or hypothalamic disease rather than reassuring yourself with a 'normal' TSH.
Review acute illness, pregnancy context, biotin, and medications before overinterpreting discordant tests.
3 · Nuance That Changes the Interpretation
Acute non-thyroidal illness (euthyroid sick syndrome) can alter thyroid tests in multiple directions. Routine thyroid testing during acute illness is discouraged unless thyroid dysfunction is clinically suspected as part of the illness.
Biotin supplements — including doses found in common hair and nail supplements — can interfere with some thyroid immunoassays and create misleading results in either direction.
T3 is often useful in suspected hyperthyroidism but is generally less useful for diagnosing hypothyroidism.
Levothyroxine timing, adherence, and interacting medications or supplements can affect TSH control.
TSH can take 6–8 weeks to equilibrate after dose changes. Repeating too early leads to over-adjustment and oscillating thyroid function.
4 · What Should Raise Concern
Severe hypothyroid symptoms with hypothermia, bradycardia, altered mental status, or other concern for myxedema coma.
Severe thyrotoxic symptoms with fever, marked tachycardia or arrhythmia, heart failure, or altered mental status.
Low FT4 with low or inappropriately normal TSH plus headache, visual symptoms, or other pituitary hormone abnormalities — central hypothyroidism requires prompt evaluation.
Apply It · Patient Scenarios
CASE 1
A patient has TSH 8.2 mIU/L and FT4 within the laboratory reference range. Symptoms are nonspecific.
CLINICAL REASONING
This is a subclinical hypothyroid biochemical pattern, not overt hypothyroidism. Confirm persistence and interpret with symptoms, TPO antibodies when appropriate, age, pregnancy status, and cardiovascular context before reflexively treating.
CASE 2
A patient has FT4 below range and TSH 1.1 mIU/L. They report headaches and new visual symptoms.
CLINICAL REASONING
A 'normal' TSH is not reassuring when FT4 is low. TSH is inappropriately normal for the low hormone level, raising concern for central hypothyroidism from pituitary disease. The headaches and visual symptoms add urgency. This requires prompt evaluation — not reassurance.
NOW CHANGE ONE DETAIL
Same patient as Case 1. Now TSH is low and FT4 is high, with palpitations and weight loss.
UPDATED REASONING
Low TSH with high FT4 and palpitations or weight loss shifts the pattern to overt thyrotoxicosis. Determine the etiology — Graves' disease, toxic nodule, thyroiditis, or exogenous thyroid hormone — rather than simply labeling 'low TSH.'
The etiology determines management. Graves' disease, toxic nodular disease, and thyroiditis have different treatment approaches.
Understand It · The Nuance
The same TSH of 8.2 can represent subclinical hypothyroidism, overt hypothyroidism with a borderline FT4, or a transient finding during recovery from acute illness. The FT4 and clinical context are what separate them.
TSH and FT4 as a pair
TSH reflects pituitary signaling to the thyroid; FT4 reflects circulating unbound thyroxine. In most adults with an intact pituitary, TSH is an excellent first test. But pairing abnormal TSH with FT4 distinguishes overt from subclinical disease and identifies patterns that do not fit primary thyroid disease.
Central hypothyroidism
Low or inappropriately normal TSH with low FT4 suggests central hypothyroidism from pituitary or hypothalamic disease — not reassurance. A 'normal' TSH is not reassuring when FT4 is low. This pattern requires prompt evaluation for pituitary disease.
Non-thyroidal illness
Acute non-thyroidal illness (euthyroid sick syndrome) can alter thyroid tests in multiple directions. Routine thyroid testing during acute illness is discouraged unless thyroid dysfunction is clinically suspected as part of the illness.
Biotin interference
Biotin supplements — including doses found in common hair/nail supplements — can interfere with some thyroid immunoassays and create misleading results in either direction. Ask about supplement use before interpreting discordant thyroid tests.
TSH equilibration after dose changes
TSH can take 6–8 weeks to equilibrate after a levothyroxine dose change. Repeating TSH too early leads to over-adjustment and oscillating thyroid function. Timing of the last dose relative to blood draw also affects FT4 levels.
Clinical Pearl: Interpret TSH and FT4 as a pair, then check whether the pattern fits primary thyroid disease, central disease, medication or supplement effects, or acute illness.
Bottom Line
Interpret TSH and FT4 as a pair, then check whether the pattern fits primary thyroid disease, central disease, medication or supplement effects, or acute illness.
TSH alone does not always tell you whether the thyroid is underactive or overactive.
Low FT4 with a low or inappropriately normal TSH suggests central hypothyroidism — not reassurance.
Subclinical hypothyroidism (high TSH, normal FT4) requires confirmation of persistence before treatment decisions.
Biotin supplements can interfere with thyroid immunoassays — ask about supplements before interpreting discordant results.
Avoid routine thyroid testing during acute illness unless thyroid dysfunction is clinically suspected.
TSH takes 6–8 weeks to equilibrate after dose changes — do not repeat too early.
Escalate when the clinical picture, trajectory, or red flags indicate a higher level of care.
EVIDENCE & REFERENCES
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. doi:10.1089/thy.2014.0028
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. doi:10.1089/thy.2016.0229